Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica
April 02, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Key Regional Health Plan Further Expands Number of Covered Lives to Over 280 Million PARSIPPANY, NJ, April 02, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced...
Interpace Diagnostics Group Reports Full Year and Fourth Quarter 2018 Financial Results
March 19, 2019 16:05 ET
|
Interpace Diagnostics Group, Inc.
Business Progress and Recent Accomplishments Highlighted and Discussed Further on Conference Call PARSIPPANY, NJ, March 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:...
Interpace Diagnostics Announces Preliminary 2018 Revenues
February 28, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Interpace to Host Fourth Quarter and Full Year 2018 Results Conference Call/Webcast PARSIPPANY, NJ, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock
January 29, 2019 16:20 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the closing of its previously announced...
Interpace Diagnostics Announces Proposed Public Offering of Common Stock
January 24, 2019 16:35 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) announced today that it intends to offer and sell shares of its...
Interpace Diagnostics to Present at the Fifteenth Annual NobleCon
January 24, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced that Jack Stover, Chief Executive Officer, will present at NobleConXV - Noble Capital...
Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing
November 07, 2018 06:55 ET
|
Interpace Diagnostics Group, Inc.
The Federal Employee Health Benefit BCBS Program Adds Approximately 5.3 Million Covered Lives PARSIPPANY, NJ, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
Interpace Diagnostics Presents Favorable New Data at the 88th Annual Meeting of the American Thyroid Association (ATA)
October 15, 2018 06:55 ET
|
Interpace Diagnostics Group, Inc.
ThyGenX® and ThyraMIR® Data from Clinical Experience Study Shows Positive Results PARSIPPANY, NJ, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced that...
Interpace Diagnostics Enters into Agreement with Renowned Integrated Health System
October 04, 2018 06:55 ET
|
Interpace Diagnostics Group, Inc.
Agreement with Piedmont Healthcare Covers Company’s Pancreatic Cancer Test PARSIPPANY, NJ, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) reported today that it has...